December 2005 - Washington D.C.

Please note that the following information was current at the time of the meeting.  Use caution when using these resources as some of this information may have changed.

Agenda

In the agenda summary below, click on a date or title to jump to the corresponding location on the page.

 
 
 
  9:00 AM-2:30 PM

Program Meetings:

Hepatitis B Coordinators
Hepatitis B Coordinators (Update)
Hepatitis C Coordinators
Indian Health Service

2:30 PM-3:30 PM

Hepatitis 101: Introduction to Hepatitis A-E

Summary: This workshop will be provide an overview of viral hepatitis A, B, C, D, and E, including basic epidemiology, risk factors, and prevention measures. This is designed for people new to the field of viral hepatitis, but will also serve as a good review for people who already work in viral hepatitis prevention and control.

Moderator: Joanna Buffington; DVH, CDC

3:30 PM-4:30 PM

Meeting: National Nurses Advisory Council for Hepatology & Liver Wellness

5:00 PM-6:00 PM

PL1 - Opening Plenary: Overview of a National Viral Hepatitis Prevention Strategy

Summary: This opening plenary will welcome participants to the conference and specifically to Washington D.C., and give an overview of the week’s agenda. The Director of DVH will present an overview of national hepatitis strategies for prevention, and set the tone for the entire meeting. Finally, a person living with chronic hepatitis will share a personal perspective.

Moderator: Joanna Buffington; DVH, CDC

Overview of a National Viral Hepatitis Prevention Strategy John Ward, Director, DVH, CDC

Chronic Viral Hepatitis: A Personal Perspective Ray Benson, Lead Singer, Asleep At the Wheel

8:30 AM-10:00 AM

PL2 - Adolescent and Adult Hepatitis Vaccination Update

Summary: This plenary will update participants on the current state of hepatitis A and hepatitis B vaccination among adolescents and adults at behavioral risk for these infections. It will include updates on the importance of considering these immunizations alongside other prevention activities for persons at risk for sexually transmitted diseases, the progress of the pending CDC/ACIP recommendations for adult hepatitis B immunization, and the burgeoning CDC collaborative initiative to prevent hepatitis B among adults

Moderator: John Douglas; Director, Division of STD Prevention, CDC

Critique of hepatitis B vaccination as an interdisciplinary model for preventing sexually transmitted infections
King Holmes, Center for AIDS and STD, University of Washington

What changes are new ACIP adult hepatitis B guidelines going to make?
Cindy Weinbaum, DVH, CDC

10:30 AM-12:00 PM   Workshop Session A

A1 - High Risk Adolescent Hepatitis Prevention

Summary: Providing hepatitis prevention for at risk adolescents; collaboration with schools, local government, and at-risk populations.

Moderator: John C. Canfield; Division of Adolescent and School Health, CDC

Annual Youth Leadership Conference on Asian and Pacific Islander Health (1) (PDF)
Eric Sue; BS; Stanford University

The State of Connecticut Department Viral Hepatitis Prevention in the Adolescent Population (2)
Andrea Lombard; RN, BSN, MPH; State of Connecticut Department of Public Health

Hepatitis B and Washington State Asian/Pacific Islander (API) Teens, Strenthening Linkages for Student Success (3)
Shana Johnny; RN, MN; Washington State Department of Health

A2 - Training for Viral Hepatitis Integration

Summary: A snapshot of two federally-funded training programs that focus on hepatitis integration in various settings; discussion of skills needed to facilitate successful integration training

HCV Integration into the Diffusion of Evidence Based Interventions (DEBI’s)
Moderator: Ann Shindo; Hepatitis C Coordinator, Oregon Dept. of Human Services

Enhancing Viral Hepatitis Presentations and Trainings (4)
Heather Lusk; BA/BS; Hawai`i Department of Health

Integrating Viral Hepatitis into Client Centered Counseling (5)
Dana Cropper-Williams; MPA, MHR; National Coalition of STD Directors

It’s Time to Integrate Viral Hepatitis Education and Training into HIV, STD, Corrections, and Substance Abuse Settings
Richard Controneo, Nat'l. Viral Hepatitis Education & Training Center, NY State Dept. of Health

A3 - Vaccination Strategies for Injection Drug Users

Summary: This workshop will focus on how to incorporate vaccination strategies into syringe exchange programs, serving injection drug users (IDUs).

Moderator: Jeff Rothman; AIDS Institute, NY State Dept. of Health

Adherence to Hepatitis B Virus Vaccination at Syringe Exchange Sites (6)
Frederick L. Altice; MD; Yale University

Buprenorphine Treatment On-Site Proximate to Syringe Exchange Sites As a Way to Increase Hepatitis B Vaccination (7)
Robert D. Bruce; MD, MA; Yale University

Developing a New Vaccination Strategy for Injection Drug Users (8)
Dan Bigg; BA, CRADC; Chicago Recovery Alliance

A4 - Community-Based Integration Models

Summary: This workshop will focus on integrating hepatitis prevention services, including education and vaccination, into community-based health clinics and programs. Presentations will include experience targeting high risk adolescents and adults who are seen in a variety of community-based settings, both clinical and non-clinical, in North Carolina, Miami, FL, and Washington, D.C.

Moderator: Bayo C. Willis; Centers for Disease Control and Prevention

Overcoming Barriers When Integrating Hepatitis Vaccine into Established Community Organizations (9)
Susan Thompson; RN, BA, MPH; North Carolina Department of Public Health

Hepatitis B Testing & Vaccination in a Community-Based Clinic (10)
Luis I. García; MS; Whitman-Walker Clinic

Viral Hepatitis and STD "A Match Made in Heaven" (otherwise known as Miami Florida) (11)
Lori S. Jordahl; MBA-HA; Miami Dade County Health Department

A5 - Hepatitis Vaccines: Making It a Reality in STD Clinics

Summary: This workshop will focus on experience integrating hepatitis vaccination (both A and B) into STD clinic settings. Presentations will include determining the cost effectiveness of blood testing for immunity prior to hepatitis B vaccination, initiating a new vaccine program, and implementing a statewide vaccine program for STD clinics.

Moderator: Deymon Fleming; National Center for HIV, STD & TB Prevention, CDC

The Cost Effectiveness of Determining Hepatitis Prevalence Prior to Immunization in an Urban STD Clinic (12)
Shukdeo Sankar; MD; District of Columbia Government

Initiation of Adult Hepatitis B and A/B Vaccine Program at a Sexually Transmitted Disease Clinic (13)
Pamela J. Wall; PA/C; Marion County Health Department

Implementing a Statewide Hepatitis A and B Vaccination Program in STD Clinics: The Indiana Experience (14)
Cheryl V. Pearcy; BS; Indiana State Department of Health

A6 - Viral Hepatitis Surveillance

Summary: Surveillance for acute and chronic viral hepatitis is critical for local, state, and national health officials to follow trends in viral hepatitis infections, identify possible outbreaks, and to help determine the burden of infection and disease so as to best target prevention efforts, research, and public health resources. This workshop will provide an overview of national surveillance for acute and chronic hepatitis C, a state perspective on HCV surveillance and NYC experience with acute hepatitis B surveillance.

Moderator: Lyn Finelli; DVH, CDC

New Directions in Hepatitis C Virus Surveillance
Lyn Finelli

HCV Surveillance: Connecticut's Experience in System Development (15)
Andrea Lombard; RN, BSN, MPH; State of Connecticut Department of Public Health

Surveillance for Acute Hepatitis B in New York City, 2004 (16)
Katherine Bornschlegel; MPH; New York City Dept of Health and Mental Hygiene

1:45 PM-2:45 PM   Workshop Session B

B1 - Adolescent Hepatitis Prevention via Education and Vaccination

Summary: This workshop will include information and experience on how to work with school programs, and preventing hepatitis by the use of "Liver Wellness" education for all, vaccination for high-risk adolescents, and bridging their barriers

Moderator: Dielda Robertson; Hepatitis C Coordinator, Louisiana Office of Public Health

How schools work, and how to work with schools - James Bogden, Project Director, Safe and Healthy School Project, Nat’l Assoc. of State Boards of Education

Administration of Hepatitis Vaccination Series to At-Risk Teens in the Public Health Setting, Vanderburgh County, Indiana, United States, 2005 (17)
Kelly N. Kelley; BSN, MA; Vanderburgh County Department of Health

Liver Wellness - An Effective Approach to Promoting Prevention of Viral Hepatitis (18)
Thelma King Thiel; RN, BA; Hepatitis Foundation International

B2 - Hepatitis Prevention Campaigns for Men Who Have Sex With Men

Summary: This session will highlight social marketing campaigns for MSM and discuss data from studies that may inform future marketing and intervention campaigns for MSM.

Moderator: Harold S. Levine; Principal, Levine & Co

Hepatitis Social Marketing Campaign in San Diego (19)
Deborah S. Brown; MBA; Family Health Centers of San Diego

Hepatitis A and Hepatitis B Vaccination Campaign Preferences Among Men Who Have Sex With Men (MSM) (20)
Rachele Peterson; BA; American Social Health Association

Hepatitis A and B vaccination perceptions among men who have sex with men (MSM) (21)
Rachele Peterson; BA; American Social Health Association

B3 - Chronic Hepatitis B and C: Treatment Update

Summary: In this session, an overview of currently available recommended options for treatment of chronic Hepatitis B and C will be presented, along with latest research data on side effects and effectiveness of these treatments. Additional treatments currently under research will also be shared. Discussion will include various options for accessing treatment currently available.

Moderator: Miriam Alter; Associate Director for Science, DVH, CDC

Chronic Hepatitis B & C: Treatment Update (PDF)
Michael Fried, Professor of Medicine, Director of Hepatology, University of N.C.

B4 - Enhancing Hepatitis C Prevention in Syringe Exchange Programs

Summary: This session will provide two examples of involving academic institutions in hepatitis C prevention activities that take place as part of syringe exchange programs. The advantages being (1) providing medical attention to underserved groups, (2) adding practical experience to an academic curriculum, and (3) saving valuable program monies.

Corrections: The Next Challenge for Harm Reduction In the U.S.
Moderator: Bruce Trigg; Medical Director, STD Program, New Mexico Dept. of Health

Hepatitis C Prevention in IVDUs: The Intersection of the Harm Reduction and Medical Models (22)
Serena Lauren Roth; BS; New York University School of Medicine
Paul Izak Campion; New York University School of Medicine

Implementing Viral Hepatitis Services in a Mobile Needle Exchange Program (23)
Catherine A. O'Connor; HIV Innovations/Northeastern University

B5 - Viral Hepatitis Transmission in Health Care Settings: Strategies for Prevention and Control

Summary: Transmission of viral hepatitis in ambulatory care, long-term care and other settings is increasingly recognized. Outbreaks have affected hundreds of patients, and investigations are disruptive and resource intensive. This session will highlight key findings from recent outbreaks and present strategies to improve our ability to detect transmission and protect patients.

Moderator: Valerie Curry; DVH, CDC

Recent Outbreaks: Key Findings and Common Theme
Joseph Perz, DVH, CDC

Working with Partners to Achieve Early Detection and Primary Prevention
Ian Williams, DVH, CDC

B6 - Viral Hepatitis Policy: Challenges and Opportunities

Summary: There are major gaps in programs and support for viral hepatitis prevention services in the United States. This workshop will include updates from the National Viral Hepatitis Roundtable and other partners working to fill these gaps and promote viral hepatitis prevention support and programs at multiple levels.

Moderator: Deborah Wexler; Executive Director, Immunization Action Coalition

National Viral Hepatitis Elimination Strategy (24)
Marie P. Bresnahan; MPH; American Liver Foundation

Advancing National Viral Hepatitis Policy: Challenges and Opportunities (25)
Laurie Schowalter; MPH; National Alliance of State and Territorial AIDS Directors
Laura Hanen; BA, MPP; National Alliance of State and Territorial AIDS Directors

3:00 PM-5:00 PM

Poster Session #1

The Rate of Serum HbsAg and HbsAB Among Korean Americans (26)
Dr. Haoek Lee; Univ. of Colorado School of Nursing

Using the Church as a Non-Traditional Setting for HBV Vaccination (27)
Dr. Haoek Lee; Univ. of Colorado School of Nursing

Hepatitis B-Related Mortality in the United States, 1990-2001: Analysis of Multiple Cause-Coded Death Data (28)
Helen W. Shih; BA, MPH; Los Angeles County Department of Health Services

Integrating Hepatitis Prevention Into Existing School Health Programs (29)
Kathryn L. White; MT, RN, BSN; Nebraska HHSS

Viral Hepatitis Resource Kits for Public Health Organizations (30)
Kathryn L. White; MT, RN, BSN; Nebraska HHSS

Prevalence of Hepatitis C Virus prevalence in United Arab Emirates (UAE) (31)
G.M. Monawar Hosain; MBBS, MSc, PhD

A Method for Developing and Evaluating an Integrated Risk Questionnaire (32)
Colleen A. Flanigan; RN, MS; NYS Department of Health

Hep Team Chicago: A Knock-Out MSM Program (33)
Harold S. Levine; BA; Levine & Partners, Inc

Integrating the Hepatitis Adolescent Program to Already Existing

Youth Services (34)
Claudia Patricia Teran; Dr; University of Miami

Hospital Record Reviews: The Cornerstone of Continuous Quality Improvement

for Perinatal Hepatitis B Prevention in NYS (35)
Elizabeth Herlihy; BSN, MS; NYS Department of Health

Epidemiological Aspects of Hepatitis C Virus Infection Among Pregnant Women

and Neonates in Al-Ain Medical District in the United Arab Emirates (36)
S.A. Uduman; Preventive Medicine Al-Ain (UAE)
Vaccines for Adults at High Risk - Kansas (37)
Kathleen Waters; BA; Kansas Department of Health and Environment

Viral Hepatitis: Stigmatization of Adults and Children (38)
William M. Remak; B, Sc, MT, BA, Public, He; National Association of Hepatitis Task Forces

Integrating Viral Hepatitis into Counseling: Preliminary Results (39)
Heather Lusk; BA/BS; Hawai`i Department of Health

Massachusetts Birth Hospital Hep B and Rubella Chart Review (40)
Martha Badger; RN, BSN; Massachusetts Department of Public Health

Resources for Providers for Hepatitis B Vaccination in Alternative Settings (41)
Deborah L. Wexler; MD; Immunization Action Coalition

Building a Multi-Tiered Outreach, Education and Training Campaign for the Prevention of Hepatitis B: A Model for Success (42)
Molli Conti; Hepatitis B Foundation

Integrating Hepatitis B Education into Welfare-to-Work Programs:

Results of a Pilot Study (43)
Fonta Reilly; BS; Hepatitis B Foundation

The "Safer Tattooing Practices Initiative" in the Correctional Service of Canada (44)
Kazimiera Adamowski; BA, MSW; Public Health Agency of Canada

Cultural Competency for Public Health Professionals (45)
Bruce Heath; BA; CDC

Bringing it all Together: Indiana's Viral Hepatitis Working Group (46)
Cheryl V. Pearcy; BS; Indiana State Department of Health

Department of Health and Community-Based Organization Collaboration in Viral

Hepatitis Prevention (47)
Kate Schneier; Health, Educator; New Mexico AIDS Services
Jimmy Schrock; BS, Psychology; New Mexico AIDS Services

State of Connecticut Department of Public Health Perinatal Hepatitis B Case Management: The First Twelve Years – 1992 to 2003 (48)
Laura Diskavich; RN, BSN, MS, APRN, BC; State of Connecticut Department of Public Health

Use of GIS to Track Hepatitis B and C Prevention Activities: 2002 to 2005, Where Have We Been? (49)
Suzanne Speers; BA, MPH, RHIA; State of Connecticut Department of Public Health

Perinatal Hepatitis B Prevention: Case Management at the Local Health Department Level (50)
Gretchen W. Alexander; BA, BSN; City of Columbus

The Hillsborough County Perinatal Hepatitis B Prevention Project (51)
Elaine Thomas; BSP; Hillsborough County Health Department

Chicago's Birthing Hospitals Perinatal Hepatitis B Records Review (52)
Patricia Hoskins-Saffold; RN, MSN; Chicago Department of Public Health

Doors of Integration (53)
Judy Norton; BS, Health, Science; Arizona Department of Health Services

Assessment of Screening, Treatment and Prevention of Perinatal Infections in the Philadelphia Birth Cohort (54)
Amy B. Jessop; PhD, MPH; HepTREC

Follow-up of False HBsAg Positive Cases in Pregnant Women Consumes Valuable Resources (55)
Vickie J. Weeast; Colorado Department of Public Health and Environment

Hepatitis B Knowledge and Testing Practices Among Colorado Obstetric Providers (56)
Vickie J. Weeast; Colorado Department of Public Health and Environment

Evaluating a National Viral Hepatitis Training Curriculum (57)
Rachel Iverson; MA; New York State Department of Health

Excess Mortality Associated with Chronic Hepatitis B Virus Infection: The Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer (58)
Uchenna H. Iloeje; MD, MPH, FACP; Bristol-Myers Squibb

Identifying Chronic Hepatitis B Infected Subjects at Risk of Liver Cirrhosis: The Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer (59)
Uchenna H. Iloeje; MD, MPH, FACP; Bristol-Myers Squibb

Assessing the Hepatitis-Related Educational Needs of Clinical Care Providers (60)
Leigh Guarinello; MPH; Inova Health Systems

Elevated Serum Level of Hepatitis B Virus (HBV) DNA is an Independent Risk Factor for Hepatocellular Carcinoma: The Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer (THE R.E.V.E.A.L.- HBV Study) (61)
Uchenna H. Iloeje; MD, MPH, FACP; Bristol-Myers Squibb

Government Working with Youth to Prevent Hepatitis: Model Development and Best Practices (62)
Annie J. Lacoursiere; BA, Hon, Comms; Government of Canada

Integrating Hepatitis Prevention Messages into HIV Prevention Services (63)
Sandra Van Sant; MPH, MN; NJDHSS

Florida Birthing Facilities' Hepatitis B Screening and Vaccination Practices (64)
Laura A. Kearns; MPH; CDC, National Immunization Program

Closing the Gap on Adult Hepatitis Vaccination in New York State (66)
Elizabeth Herlihy; RN, BSN, MS; New York State Department of Health

An Update of Washington State Perinatal Hepatitis B Program (67)
Shana Johnny; RN, MN; Washington State Department of Health

Claire Norby; Washington State Department of Health Hepatitis Outreach for High-Risk Individuals in Vigo County, Indiana (68)
Carolyn LaMar; ANP; Vigo County

Bridging the Gap: Carver County, Minnesota's Hepatitis B Jail Vaccination Program (69)
Cheri D. Reyes; MPH; Minnesota Department of Health Pauline Herrmann; RN; Carver County

Developing a Comprehensive Community-Based Hepatitis B Prevention Program: The Asian-American Hepatitis B Program in New York City (70)
Thomas Tsang; MD, MPH; Charles B. Wang Community Health Center
Henry Pollack; MD; New York University School of Medicine

Screening Asian Immigrants for Hepatitis B: Does Previous Immunization Count? (71)
Karen E. Kim; MD, MS; University of Chicago

Integration of Hepatitis C Counseling and Testing Services into Public Health Settings in California (72)
Lori Fries; MPH; California Department of Health Services

4:00 PM-5:00 PM    Workshop Session C

C1 - Interpreting Basic Viral Hepatitis Serology

Summary: This workshop will provide the attendee with basic viral hepatitis serologic profiles, interpretation of those profiles and case studies to apply that information. There will be ample time for question and answer periods during and at the end of the workshop.

Moderator/Presenter: Linda A. Moyer; DVH, CDC

8:30 AM-10:00 AM

PL3 - Progress Toward Reducing Perinatal and Childhood Viral Hepatitis

Summary: This plenary will review the progress and next steps towards reducing perinatal and childhood hepatitis B infections from national and local perspectives. Reduction of childhood hepatitis A will be discussed through a review of hepatitis A epidemiology and the rationale for routine childhood immunization.

Moderator: Nancy Fasano; National Immunization Program, CDC

Progress Towards Elimination of Perinatal and Childhood Hepatitis B Infections
Eric Mast, Chief, Prevention Branch, DVH, CDC

Implementing New Perinatal and Childhood Hepatitis B Recommendations: A City Health Department Perspective
Julie Morita, Medical Director, Immunization Program, Chicago Department of Health

The Epidemiology of Hepatitis A in Children and the Rationale for Routine Hepatitis A Immunizations

Beth Bell, Chief, Epidemiology Branch, DVH, CDC

10:30 AM-12:00 PM   Workshop Session D

D1 - Addressing the Challenges to Ensuring a Birth Dose of Hepatitis B Vaccine

Summary: Presentation on challenges to reinstating the birth dose of hepatitis B vaccine followed by an expert panel discussion on overcoming barriers.

Moderator: Lisa Jacques-Carroll ; NIP, CDC

Challenges to Reinstating the Hepatitis B Birth Dose in NYS (73)
Elizabeth Herlihy; RN, BSN, MS; New York State Department of Health

Expert Panel Discussion - Deborah Wexler (IAC) , Beverly Sheets (Indiana Dept. of Health), and Robert Frenck (UCLA School of Medicine and AAP)

D2 - Models for Reaching Out: Developing Culturally Competent Hepatitis Prevention Programs

Summary: This workshop will highlight program models that have proven successful in providing culturally competent viral hepatitis services to communities of color. Specific programs designed for Hispanic/Latinos, African Americans, and Asian Pacific Islanders will be presented and discussed.

Moderator: Marian McDonald; Associate Director for Minority & Womens' Health, NCID, CDC

Developing Culturally Responsive Prevention Strategies: Practices and Challenges
Julio Dicent Taillepierre, NCHSTP, CDC

Working with Clinicians Serving Mobile and Latin American Immigrant Populations to Prevent Hepatitis: the HepTalk Project (74)
Edward L. Zuroweste; MD; Migrant Clinicians Network

Hepatitis B Prevention & Education Symposium: Building Partnerships with Traditional Chinese Medicine (TCM) Practitioners (75)
Eric Sue; BS; Stanford University

D3 - Hepatitis Infection in IDUs: Current Epidemiologic Trends

Summary: In this session, an overview of hepatitis epidemiology among IDUs will be shared, followed by results from research projects looking at Hepatitis A, B and C among IDUs. Risk behaviors and preventive care acceptance (e.g. vaccine) will be discussed.

Moderator: Ian T. Williams; DVH, CDC

Hepatitis A and B virus (HAV and HBV) seroprevalence and structural factors associated with vaccine uptake among younger injection drug users (IDUs) in 5 U.S. cities (76)
Cindy Weinbaum; MD, MPH; Centers for Disease Control and Prevention

Trends in Hepatitis B and C Seroprevalence in Young Seattle-Area Injection Drug Users (77)
Richard Burt; PhD; Public Health - Seattle & King County

Awareness of hepatitis C virus serostatus and risk behavior in young injection drug users in 5 US cities (78)
Holly Hagan; MPH, PhD; National Development and Research Institutes

D4 - Integrating HCV Prevention in Substance Abuse Programs

Summary: This session presents examples of how hepatitis C prevention and care activities were integrated into substance abuse programs by either directly providing services or improving access to care.

Moderator: Danni Lentine; National Center for HIV, STD & TB Prevention, CDC

Experience Integrating HCV Education and Treatment in Substance Abuse Clinic (79)
Norah M. Sullivan; MSN; VA Puget Sound Health Care System

Integrating Hepatitis Counseling and Testing in Substance Abuse Programs (80)
Barbara Rush; NA; The Center for Drug Free Living, Inc

National Forum on Crack Cocaine and Hepatitis C Virus (HCV) (81)
Tracey Donaldson; BA, MSW; Public Health Agency of Canada

D5 - Developing State and Local Partnerships

Summary: This workshop will explore collaborations and partnerships that are essential to the successful integration of viral hepatitis prevention education and services.

Moderator: Victoria Moody; DVH, CDC

The Florida Hepatitis Collaboration, Assessment, Resources, and Education (FL Hep-CARE) Project: Care and Treatment for Viral Hepatitis (82)
Caroline Rains; MD; Alachua County Department of Health

Community and Public Health Partnerships for Planning and Implementation of Comprehensive Hepatitis Prevention Services (83)
Eric Rude; MSW; New York City Department of Health and Mental Hygiene
Karen Gonzales; BA; New Mexico Department of Health
Ana "Bertie" Lozano; BA; Pima County Health Department

D6 - Hepatitis Prevention and Care in Corrections and Beyond...

Summary: This workshop will include experiences with hooking inmates who are started on treatment for hepatitis C while in prison, to continued care when released, and experience vaccinating inmates in both jail and prison settings.

Moderator: Norm Fikes, National Center for HIV, STD and TB Prevention, CDC

Hepatitis C Treatment Continuity Program (84)
Lester N. Wright; MD, MPH; New York State Department of Correctional Services

Adult Hepatitis A & B Immunization of Women at Cook County Jail, Sheriff's Female Furlough Program (85)
Corinna Dan; RN; Chicago Department of Public Health

Implementing Routine Hepatitis B Vaccination in the Incarcerated Setting (86)
Josiah D. Rich; MD, MPH; Brown University

2:00 PM-3:00 PM   Workshop Session E

E1 - Childhood Hepatitis A Epidemiology and Prevention

Summary: This workshop will cover epidemiology of hepatitis A among children, and the impact of vaccination strategies from both the national and state perspective.

Moderator: Beth Bell; DVH, CDC

Modelling Hepatitis A in the United States (87) (PDF)
Companion to the slides (PDF)
Thierry Van Effelterre; PhD; GlaxoSmithKline Biologicals

Incidence of Hepatitis A in Arizona after the Implementation of Vaccination for Young Children (88)
Laura M. Erhart; MPH; Arizona Department of Health Services

E2 - Living With Hepatitis C: Getting the Information You Need

Summary: This workshop will explore issues related to living with HCV infection. Materials developed by the South Bronx Hepatitis C Task Force, and the Live Longer Project, an educational program for people living with hepatitis C, will be described. There will be discussion of approaches to helping people with hepatitis C access health and support services.

Moderator: Oksana Bilukha; DVH, CDC

How to Stay Healthy and Informed: Resources from the South Bronx Hepatitis C Task Force
Eric Rude, Hepatitis C Coordinator, NYC Department of Health and Mental Hygiene

The Live Longer Project (89)
Judy Norton; BS, Health, Science; Arizona Department of Health Services

E3 - Immunization Registries: Use for Tracking Adolescent and Adult Immunizations

Summary: This workshop will explore the successes and barriers to implementing registries to track hepatitis B vaccination of adolescents and adults, including completion of the vaccine series.

Moderator: Gary Urquhart ; National Immunization Program, CDC

Immunization Registry Support for Prevention of Adolescent and Adult Hepatitis
Karen White, Minnesota Immunization Information Connection, MN Dept. of Health

Using Immunization Registries for Adult Vaccine Tracking: The Washington, D.C. Experience
Rosie McClaren, Immunization Program Manager, Washington, D.C. Department of Health

E4 - Comprehensive HCV Prevention and Care in Substance Abuse Programs

Summary: This session provides examples of comprehensive hepatitis prevention and care delivery models. One model provides a wide spectrum of services within a single facility which is familiar and acceptable to clients. The other provides comprehensive care by coordinating and integrating several drug treatment and primary care facilities to facilitate access to care.

SAMHSA Hepatitis A and B Vaccine Initiative
Moderator: Robert Lubran; Substance Abuse and Mental Health Services Admin

Implementing a Comprehensive Hepatitis C (HCV) Prevention Program within a Residential Drug Treatment Program (90)
Marguerite Gebhardt; MPS, RN; Project Samaritan Health Services

A Model Program for Integrating Hepatitis C Management within Opioid Treatment Programs (OTPs) (91)
Alain H. Litwin; MD, MPH; Albert Einstein College of Medicine
Irene Soloway; BFA, RPA; Albert Einstein College of Medicine

E5 - Hepatitis C Education and Care for Veterans

Summary: This workshop will focus on education and knowledge of hepatitis C among veterans with chronic HCV infection, including pre- and post-test results around educational classes. In addition, experience with an alcohol intervention toolkit for use in various clinic settings where veterans are seen will be presented.

Moderator: Lawrence Deyton; Public Health, US Dept. of Veterans Affairs

Demographic, diagnostic, and health behavior correlates of HCV knowledge regarding viral routes of transmission and disease risk factors (92)
John W. Davison; MBA, PhD; VA Puget Sound Health Care System

Improving Hepatitis C Care For Veterans: Development of a Brief Alcohol Intervention Toolkit (93)
John W. Davison; MBA, PhD; VA Puget Sound Health Care System

Effectiveness of a hepatitis C group education class in Veterans Administration treatment settings (94)
John W. Davison; MBA, PhD; VA Puget Sound Health Care System

E6 - Hepatitis Prevention for American Indian and Alaska Native Populations

Summary: This workshop will focus on viral hepatitis prevention services integrated into various venues that serve Alaska Native and American Indian populations that may be at high risk for hepatitis. Counseling and testing for HCV infection, as well programs to promote vaccination and mechanisms to evaluate services will be covered.

Moderators: John Redd; IHS, DVH, CDC and Cecile M. Town; IHS, DVH, CDC

Developing Viral Hepatitis Screening and Prevention Services for American Indians and Alaska Natives at an Urban Chemical Dependency Treatment Facility (95)
Mei Castor; MD, MPH; Urban Indian Health Institute; Seattle Indian Health Board
Shelly Huffman; MPH; Seattle Indian Health Board

Linking Laboratory Surveillance, Primary Care Medical Programs, And Community-Based Activities To Provide Viral Hepatitis Prevention Programs For Higher Risk American Indian Individuals (96)
Charlton Wilson; MD; Phoenix Indian Medical Center

Interior Alaska
Kathleen Cunniffe, RN

3:30 PM-5:00 PM   Workshop Session F

F1 - Evaluation of Perinatal HBsAg Identification Based on Universal Reporting Mechanisms

Summary: Discussion of methods to evaluate perinatal hepatitis B prevention identification using birth certificate and newborn screening data.

Moderator: Susan Wang; DVH, CDC

Accuracy of Birth Certificate Data on Reporting Hepatitis B Screening in Pregnant Women (97)
Wendy Lee Griffin; RN, BSN, MSPH; Colorado Department of Public Health and Environment

Evaluation of newborn screening data in Michigan
Pat Fineis, Michigan Department of Community Health

Alabama’s Retrospective Review of Births
Tasneem Malik, NIP

F2 - Education and Resources for Persons Co-infected with HIV and HCV

Summary: This workshop will include epidemiologic data from Michigan’s surveillance activities on estimates of HCV and HIV co-infection in the southeast part of Michigan, followed by presentation and discussion of the educational and support services that are available and should be advocated for persons with co-infection and providers who care for such persons.

Moderators: Richard Controneo, Director, HIV Education & Training Programs, NYS DOH;, Judy V. Schmidt, National Immunization Program, CDC/NIP

Hepatitis C-HIV Co-infection in Southeast Michigan, 2000-2002 (98)
Linda L. Wotring; Ph, D, MPH; Michigan Department of Community Health

HIV/HCV Co-infection: Treatment Can Work, Support Services Are Essential, Advocacy is a Must!
Jules Levin, Executive Director, National AIDS Treatment Advocacy Project

F3 - Clinical and Educational Tools for Managing Chronic Hepatitis C Virus Infection

Summary: This workshop will focus on integrated clinical care for patients with chronic hepatitis C virus infection, including vaccinating against hepatitis A and B, screening for and managing co-morbid psychiatric conditions and substance use disorders, and providing patient education. It will also provide an overview of educational materials and products developed and available for both patients and providers by the VA Hepatitis C Resource Centers.

Moderator: Joanna Buffington; DVH, CDC

Diagnosed With Hepatitis C ? An Overview of What's Next
Peter Hauser, Portland Veterans Affairs Medical Center

Evaluating Universal Vaccination against Hepatitis A and B in Patients with Chronic Hepatitis C (99)
Helen S. Yee; PharmD; Department of Veterans Affairs Medical Center, San Francisco

Integrated Care Models for HCV+ Veterans with Co-morbid Psychiatric and Substance-Use Disorders (100)
Betsy L. Zucker; FNP; Portland Veterans Affairs Medical Center
Peter Hauser; MD; Portland Veterans Affairs Medical Center

Hepatitis C Treatment Issues: Clinical and Biological Perspectives (101)
David W. Indest; PsyD; Portland Veterans Affairs Medical Center
Julie A. Nelligan; PhD; Portland Veterans Affairs Medical Center

F4 - Hepatitis Integration into HIV Prevention Programs for Injection Drug Users

Summary: This workshop will focus on integrating viral hepatitis prevention activities into existing HIV prevention programs that target injecting drug users.

Moderator: Walter Chow; National Center for HIV, STD & TB Prevention, CDC

Viral Hepatitis and HIV Prevention Program Integration for Injection Drug Users (102)
Danni Lentine; MPH; CDC

Integrating Hepatitis C into HIV Prevention for Injecting Drug Users (103)
Vicki Lynn Sickels; LMSW, CADC; The AIDS Project of Central Iowa

Incorporating Hepatitis C Counseling and Testing into existing HIV Counseling and Testing services among Injection Drug Users (104)
Clark S. Marshall; BS; State of California

F5 - Hepatitis Prevention and Education in Corrections: Just Do It!!

Summary: This workshop will include a variety of tools to help deliver hepatitis educational messages and vaccination services to inmates and staff in correctional settings.

Moderators: Laurie Reid; National Center for HIV, STD & TB Prevention, CDC, and Hugh Potter; National Center for HIV, STD & TB Prevention, CDC

Hep C Inside and Out: Prevention for Inmates and Reentry Populations (105)
Kathy Jensen; MSW; Hep C Connection

Effective Viral Hepatitis Program in Jails and Prisons (106)
Denise R. Diefenbach; MEd; Maricopa County Department of Public Health

Hepatitis B Program for Juvenile Correctional Facilities (107)
Beatriz E. Builes; MPH; CDC
M.'Kiaira Kimathi Miriti; PhD; CDC

F6 - HRSA – Bureau of Primary Health Care and Community Health Centers

Summary: Community Health Centers funded by HRSA are a critical resource for persons who are under- or un-insured, many of whom have substantial health problems. This workshop will focus on access and delivery of both preventive and primary care services to persons at risk for viral hepatitis infections.

Moderator: Jay Anderson; Bureau of Primary Health Care, HRSA

7:30 AM-8:30 AM

Breakfast Panel - Developing and Implementing State Viral Hepatitis Prevention Plans

Summary: Viral Hepatitis Prevention Plans play an important role in the strategy to control and prevent viral hepatitis. These plans provide the road map for prioritizing development of prevention activities, for integrating hepatitis prevention activities into existing public health programs and for obtaining resources to achieve implementation of prevention activities. The speakers in the workshop will provide information about the development and implementation of their State Viral Hepatitis Prevention Plans discuss the accomplishments to date, and the lessons learned.

Moderators: Hope King; DVH,CDC, and Dick Moyer; DVH, CDC

Iowa Department of Public Health--Viral Hepatitis Plan
Chris Taylor, Hepatitis C Coordinator, IA Dept. of Health

Massachusetts – Hepatitis C: 2001-2005 Recommendations of the Hepatitis C Advisory Committee
Dan Church, Hepatitis C Coordinator, MA Dept of Health

New Mexico-A Vision and Strategy: Hepatitis C In New Mexico
Karen Gonzales, Hepatitis C Coordinator, NM Dept of Health

Oregon Hepatitis C Strategic Plan- Recommendations of The Viral Hepatitis Planning Group
Ann Shindo, Hepatitis C Coordinator, OR Dept of Health

8:30 AM-10:00 AM

PL4 - Viral Hepatitis Prevention for IDU: What is it and What Should We be Doing?

Summary: While Injection Drug Users (IDU) prevention efforts have been focused on HIV and politicized by syringe exchange, basic questions remain about effective viral hepatitis prevention and control interventions. This plenary will review epidemiologic, scientific and programmatic aspects of viral hepatitis prevention in IDU including hepatitis C epidemiology, a framework and the underlying science for considering prevention strategies, and the components of a comprehensive prevention strategy with examples of how they are being implemented.

Moderators: T. Stephen Jones; Consultant to CDC's Divisions of Viral Hepatitis and HIV/AIDS Prevention, and Miriam Alter; Associate Director for Science, DVH, CDC

Epidemiologic Update: Hepatitis C
Miriam Alter, DVH, CDC

Framing the Issues: Reflections on Epi, Science, Program and the Future of Viral Hepatitis Prevention for IDU
Stephen Jones

Hepatitis Prevention for IDU: What Do We Know?
David Vlahov, Director, Center for Urban Epidemiologic Studies, New York Academy of Medicine

What Should We Be Doing? Designing and Implementing a Comprehensive Hepatitis Prevention Strategy for IDU
Guthrie Birkhead, Director, NY State AIDS Institute

10:00 AM-12:00 PM

Poster Session #2

A Pilot Project to Provide Hepatitis B Vaccine to Adults in the Public Health STD Clinic Setting (65)
Julie S. Townsend; MS; Texas Department of State Health Services

Hepatitis B Vaccine Coverage among Adults Tested for HIV in the United States (108)
Kaafee Billah; PhD; Centers for Disease Control and Prevention (CDC)

DEBI-Izing an Oregon Harm Reduction Program Targeting HIV and HCV Prevention among People who Inject Drugs (109)
Ann Shindo; PhD; Oregon Dept. of Human Services

A Review of Hepatitis Infection in Pakistan (110)
Altaf Bosan; MD; Federal EPI Cell, National Institute of Health

Hepatitis C Risk Behaviors among STD Clinic Clients in Upstate New York (111)
Elena M. Rizzo; MA; NYS Department of Health

Hepatitis A and Hepatitis B Vaccination in High Risk Adults: Florida’s Experience With Integrating Services (112)
Susanne R. Crowe; MHA; State of FL Dept. of Health

Evaluation of the Florida Hepatitis and Liver Failure Prevention and Control Program (113)
Susanne R. Crowe; MHA; State of FL Dept. of Health

Receipt of Follow-up Services among Persons with Confirmed Positive Hepatitis C Virus Test Results: Wisconsin, 2004 (114)
Marjorie Hurie; RN, MS; State of Wisconsin

Programs (115)
Lois Carnicom; Indiana State Department of Health

Hepatitis Prevention Practices for Women in Prostitution (116)
Patti A. Buffington; MBA; Genesis House

HCV Testing Pilot: State of Connecticut Department of Public Health Laboratory and Viral Hepatitis Program Partnership (117)
Andrea Lombard; RN, BSN, MPH; State of Connecticut Department of Public Health

HCV Outbreak at an Oncology Clinic in Fremont Nebraska (118)
Kathryn L. White; MT, RN, BSN; Nebraska HHSS

Hepatitis B Vaccination Proximate to Syringe Exchange Sites (119)
Frederick L. Altice; MD; Yale University

Testing and Counseling for Hepatitis B, Hepatitis C, and HIV Infections in Opioid Treatment Programs (OTP’s). Summary results from two surveys (120)
Thomas F. Kresina; PhD; NIDA, NIH, DHHS

The Gold Standard of Safer Injection: A Hepatitis Preventative Injection: (121)
Dan Bigg; BA, CRADC; Chicago Recovery Alliance

Screening for Viral Infections (HIV, HBV, HCV) Among IDUs through the BEAT Program: Buprenorphine Easy Access to Treatment (122)
Robert D. Bruce; MD, MA; Yale University

Hepatitis Prevention for Drug Users in Switzerland (123)
Rudolf Hotz; MSW; Swiss Office for the Reduction of Drug Related Harm

Sexual and drug-injecting behaviors among persons with HIV infection related to injection drug use—results from an interview project, 2000-2003 (124)
Andrew J. Mitsch; MPH; Centers for Disease Control and Prevention

Cost-Effectiveness of Testing Strategies for Chronic Hepatitis C (125)
Michael K. Chapko; PhD; VA Puget Sound Health Care System

Hepatitis A Infection in Injection Drug Users and Homeless Persons in Massachusetts: Responding to an Outbreak (126)
Erica Berl; DVM, MPH; Massachusetts Department of Public Health

Preliminary Results from a Hepatitis Vaccine Program Targeted to Injection Drug Users (127)
Lauretta E. Grau; PhD; Yale School of Public Health

Prevention of Hepatitis B in a Correctional System (128)
Lester N. Wright; MD, MPH; New York State Department of Correctional Services

Integration Across Jurisdictions: Enhanced Screening in a Rural AI/AN Population (129)
Cecile M. Town; MPH; US Centers for Disease Control and Prevention

Integration in the Alaskan Bush: Use of Community Health Aides to Deliver Hepatitis, STD and HIV Services (130)
Kathleen A. Cunniffe; RN, BScN, BSc, (Life, Sci; Tanana Chiefs Conference

Evaluation of Targeted Hepatitis C Virus Screening of Inmates Admitted in 2004 to the Wisconsin Adult Correctional System (131)
Gerald Gabor; Wisconsin Immunization Program

How to Work With Your State Legislature (132)
Diane Peterson; Immunization Action Coalition

Hepatitis Prevention, Testing and Treatment in a Rural Health Center (133)
Janet L. Soule; LPN-C; Panhandle Community Services

Challenges to Treatment of Hepatitis C in a Community Methadone Clinic (134)
Kenneth T. Akinaka; BA; OPIVITA

The Ribavirin Pregnancy Registry (RPR) is Established (135)
Susan Sinclair Roberts; PhD; Registries and Epidemiology, Charles River Laboratories

Perspectives on Hepatitis C Virus Epidemiology in Drug Users (136)
Holly Hagan; MPH, PhD; National Development and Research Institutes

Hepatitis C Integration Program (137)
Rodney S. Gaither; MT, MPH, CIC; Indian Health Service

Economic Impact of an Outbreak of Acute Hepatitis B and the Need for Adult Hepatitis Vaccine Funding (138)
Clayton K. Van Houten; MS; State of Wyoming

Integrating Perinatal Hepatitis C Prevention Activities into Perinatal Hepatitis B Prevention Programs (139)
Patricia Raymond-Mangan; RN; RI Department of Health

A Syringe Exchange-Based Hepatitis Prevention Campaign for Injection Drug Users in Three U.S. Cities (140)
Lauretta E. Grau; PhD; Yale School of Public Health

North Dakota Prisons Division Hepatitis Program (141)
Kathleen M. Bachmeier; Rn, BC, MS; North Dakota State Penitentiary

Building partnerships to provide prevention services in IDU populations (142)
Cheri D. Reyes; MPH; Minnesota Department of Health Alissa Fountain; BA; Access Works

HCV Risk Assessment and Screening in the Primary Care Office (143)
Steven E. Szebenyi; MD, MMM; Foundation for Healthy Living

Colleen A. Flanigan; RN, MS; NYS Department of Health Sexual Transmission of Hepatitis C Virus (HCV) among Drug Users: A Systematic Review, 1995-2004 (144)
Salaam Semaan; DrPH; Centers for Disease Control and Prevention

Hepatitis B and Hepatitis C Coinfection with HIV/AIDS in Chicago, Illinois (145)
Alicia M. Siston; MS, MPH; Chicago Department of Public Health

Prevention of Hepatitis B Virus (HBV) among Injection and Non-Injection Drug users: A Systematic Review, 1995-2004 (146)
Salaam Semaan; DrPH; Centers for Disease Control and Prevention

Hepatitis C Seroconversion is Still Occurring in Veterans (147)
Kevin L. Sloan; MD; VA Puget Sound Health Care System

Lessons Learned from a Comparison of Hepatitis Pre-Screening Protocols in Three Multiple Morbidity Mobile Testing Programs (148)
Jenny Gross; MPH, CHES; Los Angeles County, Office of AIDS Programs and Policy

Hepatitis C Virus Infection: Survey of Screening, Evaluation & Treatment Practices (149)
Louis Katz; MD; Scott County Health Department

Hepatitis Integration into Substance Abuse Treatment, Multiple Level Interventions (150)
Corinna Dan; RN; Chicago Department of Public Health

Not Just the Needles: Social Networks, Social Marketing, and Serostatus in HCV Prevention for IDUs (151)
Daniel Raymond; Harm Reduction Coalition

HCV Knowledge and Self Efficacy among Drug Treatment Program Staff (152)
Shiela Strauss; PhD; National Development & Research Institutes

Community Partners Logic Model (153)
Julie Gleason-Comstock; PhD, CHES; Wayne State University

11:00 AM-12:00 PM

G1 - Viral Hepatitis Serology: Interpreting Confusing Results

Summary: This workshop will provide the attendee with review of viral hepatitis serology that is out of the norm. The user will be able to work through confusing serologic results and understand why certain interpretations of these results are made. There will be a question and answer period during and at the conclusion of the workshop.

Moderator: Linda A. Moyer; DVH, CDC

1:30 PM-3:00 PM   Workshop Session H

H1 - Tips for Safe and Effective Hepatitis B Case Management

Summary: Field workers describe strategies for effective case management including program evaluation, cultural competency, and personal safety during site visits.

Moderator: Amy Warner; Colorado Department of Public Health and Environment

Indiana's Perinatal Hepatitis B Prevention Program (154)
Susan E. Sparks; ASN, BGS, MAE; Indiana State Department of Health

Cultural Competency
Dr. Samuel So, Asian Liver Center

Safety Issues in the Field
Chang Lee, Washington, DC STD Program

H2 - Hepatitis Education Challenges in Substance Abuse Settings

Summary: This workshop will describe some of the challenges of providing hepatitis training to staff in drug treatment programs. Successful programs and strategies for motivating staff to address viral hepatitis will be shared.

Moderator: Karen Hennessey; DVH, CDC

Critical Components of Hepatitis Prevention Education for HealthCare Providers for Substance Users (155)
Robert D. Bruce; MD, MA; Yale University

A Drug Treatment Program Staff Training on Hepatitis C: The Importance of a Motivational Approach (156)
Janetta Astone-Twerell; PhD; National Development & Research Institutes

Piloting a Staff Training on Hepatitis C at Drug Treatment Programs: Translating Research into Practice (157)
Shiela Strauss; PhD; National Development & Research Institutes

H3 - Integration into HIV Programs: The Role of AIDS Directors and AIDS Service Organizations

Summary: Overlapping risk groups, routes of transmission, and interventions make integration of viral hepatitis prevention activities into state and community based HIV programs a natural fit yet many challenges remain. Cross-program training, planning, counseling messages, referral services, vaccination strategies, funding and evaluation are all critical programmatic issues that must be addressed before fully integrating viral hepatitis interventions into HIV programs. In this session two state AIDS Directors and a staff member from an AIDS Service Organization (ASO) will describe the challenges and successful strategies to integrating hepatitis into their AIDS programs.

Moderator: Kevin O'Connor; DVH, CDC

AIDS Directors' Experience: Integration of HIV, STD and Hepatitis Services (158)
Peter M. Whiticar; MA; Hawaii Department of Health

Come Together, Right Now Viral Hepatitis Integration
Pat Young; Iowa Department of Health

The Role of AIDS Service Organizations in Hepatitis Prevention (159)
Carlos Martinez; AIDS Action Committee

H4 - Chronic Hepatitis C: Access to Care for Under- and Un-Insured Patients

Summary: This workshop will offer three models for comprehensive care and treatment for patients with chronic hepatitis C who are under- or un-insured, using primary care models.

Moderator: Thomas F. Kresina; National Institute for Drug Abuse, NIH

Taking on Hepatitis C in Maryland
Michael Rudman, Hepatitis Clinic, Frederick, MD

Taking on Hepatitis C in San Francisco
Barry Zevin, Tom Waddell Clinic, San Francisco, CA

Taking on Hepatitis C in Methadone Clients
Diana Sylvestre, OASIS, Oakland, CA

H5 - State-Wide Lessons in Integration

Summary: This workshop will include models of integrating hepatitis services in a variety of settings and through collaborations with local, state, and national partners. Experiences from New York State, Iowa, Hawaii, and New Mexico involving multiple programs within health departments and communities will be presented.

Moderator: Laurie Schowalter; National Alliance of State and Territorial AIDS Directors

Models of Viral Hepatitis Integration and Collaboration: Health Department Perspectives (160)
Heather Lusk; BA/BS; Hawai`i Department of Health
Chris Taylor; MPH; Iowa Department of Public Health

Integration of Hepatitis Prevention & Vaccine into DEBI Interventions, existing HIV Prevention & Harm Reduction Programs in New Mexico (161)
Jimmy G. Schrock; BS, in, Psychology; New Mexico AIDS Services
Melissa Heinz Bennett; MPH; New Mexico Department of Health

Say It Like It's One Word: HIV/STD/Viral Hepatitis (162)
Richard Cotroneo; MA; New York State Department of Health
Dana Cropper-WIlliams; MPA, MHR; National Coalition of STD Directors
Colleen Flanigan; RN, MS; NYS Department of Health
Elizabeth Herlihy; RN, BSN, MS; New York State Department of Health

H6 - Models of Hepatitis Vaccination in Substance Abuse Treatment Settings

Summary: This workshop provides strategies used by local, state, and national-level programs to successfully integrate hepatitis vaccination services into substance abuse settings

Moderator: Judy V. Schmidt; National Immunization Program, CDC

A Pilot Hepatitis Vaccination Program For Substance Abuse Treatment Settings (163)
Kenneth Hoffman; MD; CSAT, SAMHSA, DHHS

Developing a Hepatitis A and B Vaccination Model within an Outpatient Opioid Treatment Program (164)
Andrea Lombard; RN, BSN, MPH; State of Connecticut Department of Public Health

Integrating viral hepatitis services into residential drug treatment programs: the Addiction Recovery Hepatitis Intervention Project (ARHIP) (165)
Andra L. Thomas; Hep-C ALERT, Inc

3:30 PM-4:30   PM Workshop Session I

I1 - Hospital Based Assessment of Hepatitis B Screening of Pregnant Women

Summary: Presentation and discussion of findings of two states’ birth hospital record reviews

Moderator: Debbie Purton; Oklahoma Immunization Program

Hepatitis B Screening in Pregnant Women and Vaccine Birth Dose Administration in Newborns: A Review from Selected Indiana Hospitals (166)
Jennifer J. McCarthy; BS; Indiana State Department of Health

Study of Hospital Perinatal Hepatitis B Prevention Practices for Women with No Prenatal Care, California 2004 (167)
Celia Woodfill; PhD; California Department of Health Services

I2 - A Video-Based HCV Educational Curriculum for High-Risk Drug Users

Summary: A video-based HCV educational curriculum for high risk drug users will be aired, followed by discussion of the contents and how this has been, and could be used in other settings.

Moderator: Jonathan Powell; DVH, CDC

A Video-based HCV Educational Curriculum for High-Risk Drug Users (168)
Diana L. Sylvestre; MD; O.A.S.I.S

I3 - Methamphetamine Use and Sexual Risk Behavior Among MSM

Summary: Methamphetamine use is becoming increasingly common, and is contributing to increases in HIV and STD among MSM in the U.S. This workshop will include a description of the increasing methamphetamine problem, links to increasing risky sex behaviors among MSM linked to HIV and STD transmission, and discuss the potential for increases in viral hepatitis in this population. Discussion will also include the importance of increasing viral hepatitis prevention and control efforts among MSM.

Moderator: Kevin O'Connor; DVH, CDC

Addressing Methamphetamine Use and Sexual Risk Behavior
David Purcell and Gordon Mansergh, National Center for HIV, STD & TB Prevention, CDC

I4 - Impact of Hepatitis in Frontier Settings

Summary: In this workshop, presenters will describe the impact of hepatitis on rural communities including descriptions of high risk activities that are most prevalent. The workshop will also describe interventions that have proven effective in these communities.

Moderator: Steven Wiersma; World Health Organization

Addressing Hepatitis C in Substance Abuse Treatment in Frontier Communities (169)
Bridget Giovale; BS; Southwest Counseling Service

Hepatitis A Outbreak Among Injection Drug Users Along the Texas-Mexico Border (170)
Gary Heseltine; MD, MPH; Texas Dept. of State Health Services

Viral Hepatitis Risks among Methamphetamine Injectors: A Qualitative Follow up Study of an Acute Hepatitis B Outbreak (171)
Clayton K. Van Houten; MS; State of Wyoming

I5 - Implementation and Evaluation of Integrated Hepatitis Services

Summary: This workshop will include experiences from two states and a national project to evaluate the process and impact of integrating viral hepatitis prevention services into existing public health programs.

Moderator: Thomas Bertrand; STD Director, Massachusetts Dept. of Health

Evaluating the Impact of Viral Hepatitis Integration in Public Health Settings (172)
Jennie L. Harris; MPH; RTI International

Massachusetts Viral Hepatitis Integration Program Evaluation (173)
Daniel Church; MPH; Massachusetts Department of Public Health

Implementing Delivering and Evaluating Viral Hepatitis Services Into Multiple STD Clinics (174)
Richard Joseph Zimmerman; MS; IL Department of Public Health

I6 - Hepatitis C Integration into Substance Abuse Treatment: Projects Supported by the Substance Abuse and Mental Health Services Administration (SAMHSA)

Summary: This workshop will showcase projects in Massachusetts, New York, and Los Angeles funded by SAMHSA to incorporate hepatitis C training and education into substance abuse treatment programs.

Moderator: David Thompson; SAMHSA

Developing and implementing hepatitis C training for substance abuse treatment providers in Massachusetts
MA Dept. of Public Health: Jorge Sanchez, Director of Communications, HIV/AIDS Bureau; Carolyn Castro-Donlan, Deputy Director, Bureau of Substance

Developing and implementing hepatitis C training for substance abuse treatment providers in New York State
Steven Kipnis, Medical Director, NYS Office of Alcohol and Substance Abuse Services

Hepatitis C curriculum for substance abuse treatment providers and staff
Dan George, The Matrix Institute, Los Angeles

8:30 AM-10:00 AM Workshop Session J

J1 - Ask the Experts

Summary: This workshop will be a panel of viral hepatitis experts that will answer questions on viral hepatitis prevention and control. Conference attendees will have the opportunity to provide questions throughout the week and these questions and any others that attendees might have will be answered during the workshop. Questions can be about any type of viral hepatitis and can be about any topic related to viral hepatitis.

Moderator: Linda A. Moyer; CDC

Ask the Experts - Ian Williams, Eric Mast, Donna Weaver

J2 - Hepatitis on the Internet: The Good, the Bad, and the Ugly

Summary: In an era of information overload, the ability to design and identify accurate and appropriate messages and information on viral hepatitis can be a challenge. This workshop will highlight high quality reliable internet resources available to consumers and providers and describe types of misinformation most likely to be accessed by parents searching for hepatitis B information.

Moderator: Holly R. Wilson; CDC

Interactive Viral Hepatitis Training Website (175)
Bruce Maeder; BS; University of Washington

Internet (Mis)information about Hepatitis B Virus (HBV) Infection and the Hepatitis B Vaccine (176)
Teresa Asper Anderson; DDS, MPH; Immunization Action Coalition

Everything You Could Ever Want to Know About Hepatitis – The CDC Hepatitis Internet Resource
Jonathan Powell, DVH, CDC

J3 - The Changing Role of Syringe Exchange Programs in Response to Prevention of Hepatitis

Summary: In this workshop participants will learn about the history of syringe exchange programs (SEPs) in the United States including the evolution of HIV and hepatitis prevention in these programs. The workshop will describe strategies for integration of hepatitis prevention into programs that serve adults and young injectors and tell which hepatitis interventions have been most effective.

Moderator: Stephen Koester; Professor of Health & Behavioral Sciences, University of Colorado at Denver

Beyond Syringe Access: Adapting Needle Exchange Programs to HCV Prevention (177)
Daniel Raymond; Harm Reduction Coalition

Syringe Exchange: The First 25 Years, Adapting From HIV to HBV and HCV (178)
Don C. Des Jarlais; PhD; Beth Israel Medical Center

Drug injection initiation and hepatitis C virus (HCV) infection: An assessment of opportunities for intervention (179)
Lawrence J. Ouellet; PhD; University of Illinois at Chicago

J4 - HCV Testing – Laboratory Guidelines and Rapid Diagnostics

Summary: This workshop will provide a review of CDC guidelines on testing and reporting antibody to HCV; share experience on implementation of the guidelines in laboratories through experience in Florida and results of a survey of 450 laboratories; status of rapid anti-HCV assays for serum and saliva.

Moderator: Wendi Kuhnert; DVH, CDC

HCV Laboratory Testing and Result Reporting Practices: Results of a CDC Survey
Wendi Kuhnert

Use of the Signal to Cutoff Ratio in Hepatitis C Antibody Testing in Florida (180)
Susanne R. Crowe; MHA; State of FL Dept. of Health

Rapid HCV Diagnostics in Oral Fluid
Steven Lee, OraSure Diagnostics

J5 - Models for Hepatitis Prevention and Control for Asian/Pacific Islander Communities

Summary: Strategies to provide hepatitis B prevention education, awareness, and services targeted to Asian Americans in California, Colorado, and New York City will be presented and discussed.

Moderator: Dolly Sinha; DVH, CDC

Jade Ribbon Campaign: A Culturally Targeted Global Intervention to Address the High Prevalence of Hepatitis B among Asians and Asian Americans (181)
Samuel So; MD; Stanford University

Three For Life: Protecting adult Asian/Pacific Islanders through hepatitis testing and vaccination (182)
Janet Zola; MPH; San Francisco Department of Public Health

Integration of a Participatory Research into a Church-Based Health Survey (183)
Dr. Haoek Lee; Univ. of Colorado School of Nursing

Innovative Strategies in Hepatitis B Prevention for Asian Americans in New York City - A Community Health Center's Perspectives (184)
Christina Lee; BA; Charles B. Wang Community Health Center
Deborah Hong; MPA; Charles B. Wang Community Health Center

J6- Creative Approaches to Maximizing Resources

Summary: Presenters in this workshop will share experience with trying to integrate viral hepatitis prevention services into existing programs with limited resources. Federal participants will share current mechanisms for securing vaccine for use in high risk adult settings.

Moderator: Tasneem Malik; CDC/NIP

Small Budget, Big Dreams: Missouri Hepatitis Prevention (185)
Scott Carson; MDiv; Missouri Department of Health and Senior Services

Developing HCV Infrastructure with Limited Resources (186)
Wendy Dillon; BA; Washington State Department of Health

Utilizing CDC Funding Resources
Tasneem Malik, NIP, CDC; Kevin O'Connor, DVH, CDC

10:30 AM-12:00 PM

PL5 - Approaches to Viral Hepatitis Prevention and Control: Legislative, Advocacy, and Community Action

Summary: This plenary will illustrate the successful implementation of various tools that state and local health departments, community-based organizations (CBOs), and other groups can adapt and use in their efforts to address hepatitis in their particular situations.

Moderator: Dan Riedford; DVH, CDC

From Liver Transplant Surgeon to HBV and Liver Cancer Prevention Activist
Samuel So; MD; Stanford University

ECHO Hepatitis C Initiative: Public Health Primary Care Collaborative Model
Michelle Lujan Grisham, NM Secretary of Health

Section 508 and Accessibility: Contact the DVH webmaster if you need help with accessibility for PDF content.

---

Additional Navigation for the CDC Website

• Home
• Policies and Regulations
• Disclaimer
• e-Government
• FOIA
• Contact Us